Join an innovative global community focused on improving patient care, shaping effective policy, and ensuring the future of our field.
March 25, 2024
Late-Breaking Abstracts are now being accepted for ENDO 2024, taking place June 1-4 in Boston, MA. Submitting an abstract earns media coverage for your work, connects you with scientific investigators with similar interests, and helps drive patient care for the people that need us most. Late-Breaking Abstracts will be accepted through Wednesday, April 10 at 11:59 PM ET. Learn more.
March 27, 2024
On Wednesday, April 3 at 11:00 AM ET, the Endocrine-Disrupting Chemicals (EDCs) Special Interest Group will host a webinar on how to revise EDC effects on the endocrine system, including what doctors can do to protect their patients. Our speakers will also discuss the current state of negotiations for the Plastics Treaty. Register now!
March 25, 2024
Endocrine Self-Assessment Program (ESAP™) 2024 is now available in both print and eBook formats. Elevate your expertise anytime and anywhere with 120 brand new clinical cases, performance reports, and two online learning modes. Enrich your clinical knowledge, identify areas for improvement, and remain at the forefront of endocrinology. Order now.
March 21, 2024
Winners of the Committee on Diversity and Inclusion (CoDI) Video Contest will receive free registration to ENDO 2024, admission to the Early Career Forum, and one-year free membership. The CoDI Video Contest is open until 11:59 PM ET, Friday, March 29, 2024.
March 29, 2024
CMS has updated the conversion factor for physician services, resulting in a 1.68% increase from the previous conversion factor and on March 26, the US Supreme Court held oral arguments on the Mifepristone challenge. Learn more about what these mean for you.
Need more info?
Learn more about the advantages of membership
March 25, 2024
The Endocrine Society has selected five recipients for its Early Investigator Awards.
March 14, 2024
Bariatric surgery may result in significant cardiometabolic improvements, particularly among younger, female, or white people and those without comorbidities, according to new research published in the Journal of the Endocrine Society.
March 08, 2024
The Endocrine Society applauds Congress for approving the first funding increase for the Special Diabetes Program in two decades.
March 26, 2024
The authors present a 34-year-old woman with glucocorticoid-treated NCCAH and class III obesity who underwent Roux-en-Y gastric bypass.
March 26, 2024
This study provides deeper insight into another role of mechanistic target of rapamycin modulation of mineralocorticoid receptor transcriptional activity.
March 26, 2024
We review physiological mini-puberty and consequences of central hypothalamic-pituitary-gonadal axis disorders; provide a diagnostic approach to allow for early identification of these conditions; and review current treatment options for replacement of mini-puberty in male infants with congenital hypogonadotropic hypogonadism.